Publications<< Back
Massot A, Vivanco R, Principe A, Roquer J, Rocamora R
Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results.
Neurologia. 2014 Mar;29(2):94-101, PMID: 23623701
Eslicarbazepine acetate (ESL) is a new antiepileptic drug (AED) and an analogue to carbamazepine (CBZ) and oxcarbazepine (OXC). In this study, we evaluate initial therapeutic response to ESL and events in the change from CBZ and OXC.
CLINICAL NEUROLOGY
An initiative of
